1. Home
  2. PRGO vs DBL Comparison

PRGO vs DBL Comparison

Compare PRGO & DBL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Perrigo Company plc

PRGO

Perrigo Company plc

HOLD

Current Price

$13.47

Market Cap

1.8B

Sector

Health Care

ML Signal

HOLD

Logo DoubleLine Opportunistic Credit Fund of Beneficial Interest

DBL

DoubleLine Opportunistic Credit Fund of Beneficial Interest

HOLD

Current Price

$15.33

Market Cap

292.0M

Sector

N/A

ML Signal

HOLD

Company Overview

Basic Information
Metric
PRGO
DBL
Founded
1887
2011
Country
Ireland
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.8B
292.0M
IPO Year
1991
N/A

Fundamental Metrics

Financial Performance
Metric
PRGO
DBL
Price
$13.47
$15.33
Analyst Decision
Buy
Analyst Count
4
0
Target Price
$22.50
N/A
AVG Volume (30 Days)
4.1M
61.0K
Earning Date
11-05-2025
01-01-0001
Dividend Yield
8.63%
8.67%
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$4,281,800,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$12.17
$13.75
52 Week High
$30.93
$15.70

Technical Indicators

Market Signals
Indicator
PRGO
DBL
Relative Strength Index (RSI) 32.48 46.30
Support Level $13.34 $15.21
Resistance Level $14.12 $15.47
Average True Range (ATR) 0.47 0.15
MACD 0.34 0.01
Stochastic Oscillator 66.41 45.24

Price Performance

Historical Comparison
PRGO
DBL

About PRGO Perrigo Company plc

Perrigo is one of the largest consumer health companies in the world. Since 2018, Perrigo divested its animal health and generic pharmaceuticals businesses to solely focus on consumer self-care. In North America (two thirds of total sales), the firm's product mix is anchored in private-label consumer health goods, which are sold to major retailers like Walmart, Amazon, Costco, and CVS. Perrigo also plays in Europe, Australia, and parts of Asia where it primarily generates revenue through its national brands, including Compeed, Solpadeine, Coldrex, and ellaOne.

About DBL DoubleLine Opportunistic Credit Fund of Beneficial Interest

Doubleline Opportunistic Credit Fund operates as a closed-end management investment company. Its investment objective is to seek a high total investment return by providing a high level of current income and the potential for capital appreciation. The Fund invests in debt securities, residential and commercial mortgage-backed securities, asset-backed securities, U.S. Government securities, corporate debt, international sovereign debt, and short-term investments.

Share on Social Networks: